NCT00250198View on ClinicalTrials.gov

The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 3, 2005

Study Completion Date

September 5, 2006

Conditions
Crohn's Disease
Interventions
DRUG

STA-5326

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00250198 - The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease | Biotech Hunter | Biotech Hunter